Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic Cancer

NCT03498326 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Chemotherapy Effect

Interventions

DRUG: Gemcitabine
DRUG: Gemcitabine

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University